Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire
Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected.1 Of all SSc manifestations, GI disease has the greatest impact on quality of life.2